Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,027.00",
    "chg": -109.45,
    "chgp": "-1.78%",
    "dir": -1,
    "prev_price": "6,136.45",
    "mcapval": "159,332.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE361B01024",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "4.4 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Ltd’s Volatile Week: -0.48% Amid Mixed Technical Signals and Sector Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltds-volatile-week--048-amid-mixed-technical-signals-and-sector-pressure-3826607",
        "imagepath": "",
        "date": "2026-02-07 17:05:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Downgrade to Sell amid technical weakness and valuation concerns</p>\n                    <p><strong>3 Feb:</strong> Strong gap up and intraday high at Rs.6,283.55 (+4.17%)</p>\n                    <p><strong>4 Feb:</strong> Mixed technical signals with price momentum shift</p>\n                    <p><strong>6 Feb:</strong> Intraday low at Rs.5,947.5 amid price pressure (-1.82%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,960.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"..."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 6 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-6-feb-2026-3824463",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_priceRelatedfactors_3824463.png",
        "date": "2026-02-06 13:00:52",
        "description": "Shares of Divis Laboratories Ltd declined sharply on 6 Feb 2026, touching an intraday low of Rs 5,947.5, reflecting a 3.08% drop as the stock underperformed its sector and broader market amid prevailing price pressures and subdued market sentiment."
      },
      {
        "title": "Divis Laboratories Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3819624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_technicaldot_3819624.png",
        "date": "2026-02-04 08:02:42",
        "description": "Divis Laboratories Ltd has experienced a notable shift in price momentum, reflected in a complex mix of technical indicator signals. While the stock price surged nearly 4% on 4 Feb 2026, technical assessments reveal a transition from bearish to mildly bearish trends, prompting a downgrade in its Mojo Grade from Hold to Sell. This article analyses the key technical parameters shaping investor sentiment and market positioning for this leading Pharmaceuticals & Biotechnology stock."
      },
      {
        "title": "Divis Laboratories Ltd Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3817620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_gapup_3817620.png",
        "date": "2026-02-03 09:39:05",
        "description": "Divis Laboratories Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 4.01% higher than its previous close, signalling a robust start amid positive market conditions in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday High with Strong 3.77% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-high-with-strong-377-surge-3817538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_priceRelatedfactors_3817538.png",
        "date": "2026-02-03 09:36:06",
        "description": "Divis Laboratories Ltd surged to an intraday high of Rs 6,283.55, marking a 5.42% increase as the stock demonstrated robust intraday performance amid a mixed market backdrop on 3 Feb 2026."
      },
      {
        "title": "Divis Laboratories Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3815694",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_mojoScore_3815694.png",
        "date": "2026-02-02 08:13:25",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 1 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth, despite recent positive quarterly results and strong management efficiency."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3813591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_technicaldot_3813591.png",
        "date": "2026-02-01 08:01:47",
        "description": "Divis Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest day gain of 0.33%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This analysis explores the recent technical developments, price momentum, and comparative performance against the Sensex to provide investors with a comprehensive view of Divi’s Lab’s current market positioning."
      },
      {
        "title": "Divis Laboratories Gains 0.82%: 5 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-082-5-key-factors-driving-the-weeks-mixed-momentum-3813145",
        "imagepath": "",
        "date": "2026-01-31 17:04:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock opens week with a 0.88% gain to Rs.6,058.15</p>\n                    <p><strong>Jan 28:</strong> Intraday high of Rs.6,185 reached amid 3.05% surge; Mojo rating upgraded to Hold</p>\n                    <p><strong>Jan 29:</strong> Intraday low of Rs.6,020 as stock declines 2.66%</p>\n                    <p><strong>Jan 30:</strong> Death Cross formation signals potential bearish trend; stock closes at Rs.6,054.25 (+0.26%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,005.05</div></div>\n                    <div class=\"stat-item\"><di..."
      },
      {
        "title": "Divis Laboratories Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-3811790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DivisLaboratori_dealthcross_3811790.png",
        "date": "2026-01-30 18:00:35",
        "description": "Divis Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum. Investors and market watchers should carefully analyse the implications of this event amid the company’s current financial and market performance."
      }
    ],
    "total": 567,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Feb-2026",
      "details": "Schedule of earnings conference call for Q3FY26 to be held on February 11 2026 at 15.00 hrs (IST).",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "30-Jan-2026",
      "details": "Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Ltd’s Volatile Week: -0.48% Amid Mixed Technical Signals and Sector Pressure

2026-02-07 17:05:23

Key Events This Week

2 Feb: Downgrade to Sell amid technical weakness and valuation concerns

3 Feb: Strong gap up and intraday high at Rs.6,283.55 (+4.17%)

4 Feb: Mixed technical signals with price momentum shift

6 Feb: Intraday low at Rs.5,947.5 amid price pressure (-1.82%)

Week Open

Rs.5,960.30

Week Close

Read full news article

Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 6 Feb 2026

2026-02-06 13:00:52

Shares of Divis Laboratories Ltd declined sharply on 6 Feb 2026, touching an intraday low of Rs 5,947.5, reflecting a 3.08% drop as the stock underperformed its sector and broader market amid prevailing price pressures and subdued market sentiment.

Read full news article

Divis Laboratories Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-04 08:02:42

Divis Laboratories Ltd has experienced a notable shift in price momentum, reflected in a complex mix of technical indicator signals. While the stock price surged nearly 4% on 4 Feb 2026, technical assessments reveal a transition from bearish to mildly bearish trends, prompting a downgrade in its Mojo Grade from Hold to Sell. This article analyses the key technical parameters shaping investor sentiment and market positioning for this leading Pharmaceuticals & Biotechnology stock.

Read full news article

Divis Laboratories Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 09:39:05

Divis Laboratories Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 4.01% higher than its previous close, signalling a robust start amid positive market conditions in the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Ltd Hits Intraday High with Strong 3.77% Surge

2026-02-03 09:36:06

Divis Laboratories Ltd surged to an intraday high of Rs 6,283.55, marking a 5.42% increase as the stock demonstrated robust intraday performance amid a mixed market backdrop on 3 Feb 2026.

Read full news article

Divis Laboratories Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-02-02 08:13:25

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 1 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth, despite recent positive quarterly results and strong management efficiency.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-01 08:01:47

Divis Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest day gain of 0.33%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This analysis explores the recent technical developments, price momentum, and comparative performance against the Sensex to provide investors with a comprehensive view of Divi’s Lab’s current market positioning.

Read full news article

Divis Laboratories Gains 0.82%: 5 Key Factors Driving the Week’s Mixed Momentum

2026-01-31 17:04:54

Key Events This Week

Jan 27: Stock opens week with a 0.88% gain to Rs.6,058.15

Jan 28: Intraday high of Rs.6,185 reached amid 3.05% surge; Mojo rating upgraded to Hold

Jan 29: Intraday low of Rs.6,020 as stock declines 2.66%

Jan 30: Death Cross formation signals potential bearish trend; stock closes at Rs.6,054.25 (+0.26%)

Week Open

Rs.6,005.05

Read full news article

Divis Laboratories Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-01-30 18:00:35

Divis Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum. Investors and market watchers should carefully analyse the implications of this event amid the company’s current financial and market performance.

Read full news article

View All News